- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$1.38 BnMarket Estimate, 2026
$1.44 BnMarket Forecast, 2034
$2.02 BnCAGR, 2026–2034
4.33%Executive Summary: North America Intraocular Lens Market
- Market Scope: North American ophthalmic surgery analysis covering material types (Polymethylmethacrylate, Silicone, Hydrophobic Acrylic), product categories (Monofocal, Premium, Toric, Multifocal, Accommodating, EDoF), and care settings across the United States, Canada, Mexico, and the rest of North America.
- Market Valuation: Valued at USD 1.38 billion in 2025, estimated at USD 1.44 billion in 2026, and projected to reach USD 2.02 billion by 2034, registering a stable CAGR of 4.33% (2026–2034).
- Primary Growth Drivers & Restraints: Propelled by an aging population, soaring prevalence of cataracts and diabetic retinopathy, rising preference for personalized treatment, and continuous technological enhancements (e.g., EDoF and custom lenses). Primary restraints include post-operative implantation errors, rising device costs, poor reimbursement coverage for advanced lenses, and post-surgical complications.
Key Market Segment Metrics (2026–2034)
| Category | Leading Segment / Overview | Fastest-Growing Segment / Region |
|---|---|---|
| By Material Type | Hydrophobic Acrylic & Silicone (favored for high biocompatibility, flexibility, and minimal post-surgical complications) | Advanced foldable polymer variants |
| By Lens Type | Monofocal Intraocular Lenses (widely utilized due to standardized clinical pathways and robust public reimbursement models) | Premium IOLs (Multifocal, Toric, Accommodating, and Extended Depth-of-Focus [EDoF] lenses) |
| By End-User | Hospitals and Ambulatory Surgical Centers (ASCs) (accounting for high surgical throughput and advanced ophthalmic suites) | Specialized Ophthalmology Clinics |
| By Country | United States (holding the dominant market share backed by high disposable incomes, extensive vision correction rates, and advanced tech adoption) | Canada & Mexico (expanding via improved accessibility and rising healthcare investments) |
Major Market Players & Industry Structure
Market Structure: Highly consolidated yet innovative competitive landscape dominated by major medical technology leaders continuously launching advanced customized vision correction platforms.
Key Companies: Johnson & Johnson, Valeant, Carl Zeiss Meditec AG, Rayner, Alcon Inc. (Novartis division), EyeKon Medical Inc., Lenstec Inc., HumanOptics AG, STAAR Surgical, Physiol s.a., Calhoun Vision Center, and Oculentis GmbH.
North America Intraocular Lens Market Size
The size of the North America intraocular lens market was worth USD 1.38 billion in 2025. The North America market is anticipated to grow at a CAGR of 4.33% from 2026 to 2034 and be worth USD 2.02 billion by 2034 from USD 1.44 billion in 2026.
MARKET DRIVERS
Rising Eye Disorders and Demand for Personalized Treatment Fuel IOL Market in North America
Some factors driving the growth of the market include increased demand and awareness for personalized medicine and targeted therapy, increasing cases of adverse drug reactions, and technological demands. According to the NIH National Eye Institute, more than 12.3 million Americans currently have common vision problems that can be corrected with the use of prescription glasses such as eyeglasses or contact lenses. Americans spend more than $ 15.6 billion on glasses each year. Hence, increasing ophthalmic conditions in the region is expected to drive the growth of intraocular lenses market during the forecast period.
According to the National Eye Institute, the United States recorded 7.8 million cases of diabetic retinopathy and 26 million cases of cataracts, and is expected to reach 11.9 million and 39.4 million, respectively, by 2035. In addition, the American Ophthalmological Association states that the leading cause of visual impairment worldwide is thought to be cataracts, and that geriatric eye problems are emerging as the main contributors in developing countries. Hence, such an increase in ophthalmic disorders across the U.S. and Canada is expected to drive the growth of the IOL market during the forecast period.
Postoperative Errors and Implantation Issues Restrict IOL Market Growth
There are a few challenges associated with intraocular lenses, such as confusion and errors related to intraocular lenses (IOL), which are among the most common postoperative adverse events, as well as the majority of errors related to incorrect implantation of the IOL, which restricts the market.
Recently, there has been a growing demand for high-end, state-of-the-art IOLs, such as multifocal IOLs, accommodating IOLs, presbyopia and astigmatism correcting intraocular lenses (IOLs), depth IOLs, extended field strength (EDoF). In addition to improving the quality of vision and reducing the risk of blindness, the demand for intraocular lenses is increasing.
MARKET OPPORTUNITIES AND RESTRAINTS
The growing desire of companies to capture emerging countries and gradually switch to new technologies should offer significant growth opportunities to players in this market.
MARKET RESTRAINTS
Rising costs of IOLs, poor reimbursement coverage, and post-surgical complications are expected to hamper market growth during the forecast period.
REPORT COVERAGE
| REPORT METRIC | DETAILS |
| Market Size Available | 2025 to 2034 |
| Base Year | 2025 |
| Forecast Period | 2026 to 2034 |
| Segments Covered | By Material, Type, End-user, and Region. |
| Various Analyses Covered | Global, Regional and Country-Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges; PESTLE Analysis; Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
| Countries Covered | United States, Canada, Mexico, Rest of North America |
| Market Leaders Profiled | Johnson & Johnson, Valeant, Carl Zeiss Meditec AG, Rayner, Alcon, Inc. (division of Novartis AG), EyeKon Medical, Inc., Lenstec, Inc., HumanOptics AG, STAAR Surgical, Physiol s.a., Calhoun Vision Center, and Oculentis GmBH. |
COUNTRY LEVEL ANALYSIS
In North America, the United States holds the largest share of the market and is expected to dominate during the forecast period. According to the American Academy of Ophthalmology, approximately 2.7 million eye injuries occur each year in the United States alone. Hence, the increase in eye injuries is helping the growth of the market.
Increased number of new product launches, as well as ongoing technological advancements such as EDoF and custom cataract lenses. According to the Vision Council, about 79% of adults in the United States had vision correction surgery in 2017, and about 25% of adults said they needed vision correction. These factors are contributing to the growth of the North America IOL market. However, as the impact of COVID-19 is greater in this region, a significant proportion of elective surgeries are postponed and hospitals become emergency units. Due to this, the intraocular lens market in the region is expected to register significant impact in the short term.
KEY MARKET PLAYERS
Promising Companies leading the North America Intraocular Lens Market Profiled in the Report are Johnson & Johnson, Valeant, Carl Zeiss Meditec AG, Rayner, Alcon, Inc. (division of Novartis AG), EyeKon Medical, Inc., Lenstec, Inc., HumanOptics AG, STAAR Surgical, Physiol s.a., Calhoun Vision Center, and Oculentis GmBH.
MARKET SEGMENTATION
This research report on the North America intraocular lens market is segmented and sub-segmented into the following categories.
By Material
- Polymethylmethacrylate (PMMA)
- Silicone
- Hydrophobic Acrylic
By Type
- Monofocal Intraocular Lens
- Premium Intraocular Lens
- Toric Intraocular Lens
- Multifocal Intraocular Lens
- Accommodating Intraocular Lens
By End User
- Hospitals
- Ophthalmology Clinics
- Eye Research Institutes
- Ambulatory Surgical Centers
By Country
- United States
- Canada
- Mexico
- Rest of North America